secwatch.observer — SEC 8-K summary
======================================

Issuer:     RESMED INC (RMD)
CIK:        0000943819
Form:       8-K
Filed at:   2025-01-30T23:59:59+00:00
Accession:  0001193125-25-017218
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ResMed reports Q2 FY2025 revenue up 10% to $1.28B; non-GAAP EPS $2.43, up 29%
-----------------------------------------------------------------------------

- Revenue $1.28B (+10% YoY); gross margin 58.6% (+300 bps) on manufacturing efficiencies.
- Non-GAAP diluted EPS $2.43 (+29%); operating income $417M (+52% vs $275M, prior year had $64M restructuring).
- Operating cash flow $309M; paid $78M dividends and repurchased $75M shares during quarter.
- Board declared $0.53 quarterly dividend; record Feb 13, 2025, payable Mar 20, 2025.
- Residential Care Software revenue up 8% constant currency; U.S./Canada/Latin America revenue up 12%.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/943819/000119312525017218/0001193125-25-017218-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/943819/000119312525017218/d888970d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-017218

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer